PRELUDE CAPITAL MANAGEMENT, LLC - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$5,133,000
+128225.0%
151,865
+75832.5%
0.15%
Q3 2020$4,000
-99.1%
200
-99.4%
0.00%
-100.0%
Q1 2019$454,00033,5380.03%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders